doi: 10.1163/156856208784909435
Ahn, Combination treatment with the BRAFV600E inhibitor Vemurafenib and the BH3 mimetic navitoclax for BRAF-Mutant thyroid carcinoma
Sestili, P
Psychiatry 9:189
Materials and methods Reagents and materials Oxidized glutathione (GSH) 2 , homocystine (Hcy) 2 , cystine (Cys) 2 , TCEP, benzyl bromide, 2-chloropyridine, L-lysine, N-acetylcysteine (NAC), 2-mercaptoethanesulfonic acid (MESNA), N-(2-mercaptopropionyl)-glycine (MPG), [2 S]-1-[3-mercapto-2-methylpropionyl]-L-proline (Captopril), and lipoic acid (LA), and ethylenediaminetetraacetic acid (EDTA) were received from the Sigma Aldrich Company (St
At AgeWell Medicine & Aesthetics, we are committed to offering advanced therapies that support healthy aging, vitality, and overall well-being